The medical device industry raised $1.8 billion in financing during the second quarter of 2015 – nearly double the $934 million amassed in Q1. (See Exhibit 1.) The increase is attributed to significant surges in the IPO and early-stage venture round categories.
Device/Diagnostics Quarterly Deal Statistics, Q2 2015
A look at financing, M&A and alliance activity April–June 2015
At $1.8 billion, Q2 device financing nearly doubled the Q1 total, mainly from an increase in IPOs and early VC rounds, and acquisitions were slightly higher at $4.7 billion. Diagnostics funding also increased to $784 million from Q1's $597 million, and Danaher's monster $13.8 billion buy of life sciences company Pall headlined the second quarter's $15.6 billion total in diagnostics M&A activity.